MAGNANI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 493
EU - Europa 312
AS - Asia 310
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.118
Nazione #
US - Stati Uniti d'America 481
CN - Cina 235
IE - Irlanda 173
SG - Singapore 50
IT - Italia 36
FI - Finlandia 32
DE - Germania 26
VN - Vietnam 14
CA - Canada 12
SE - Svezia 11
GB - Regno Unito 9
GR - Grecia 6
IR - Iran 5
RU - Federazione Russa 4
BE - Belgio 3
DK - Danimarca 3
NL - Olanda 3
AU - Australia 2
IN - India 2
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
FR - Francia 1
HK - Hong Kong 1
HU - Ungheria 1
KG - Kirghizistan 1
KR - Corea 1
MY - Malesia 1
Totale 1.118
Città #
Dublin 173
Chandler 110
Nanjing 65
Boardman 52
Singapore 43
Beijing 42
Ashburn 30
Lawrence 26
Medford 26
Princeton 26
Hebei 25
Wilmington 22
Helsinki 20
Jacksonville 19
Nanchang 16
Shanghai 15
Dong Ket 14
Shenyang 14
Changsha 13
Pavia 11
Toronto 10
Hangzhou 9
Jiaxing 9
Fairfield 6
Genoa 6
New York 6
Tianjin 6
Piscataway 5
Ann Arbor 4
Falkenstein 4
London 4
Brussels 3
Detroit 3
Napa 3
Norwalk 3
Redwood City 3
San Francisco 3
Woodbridge 3
Buccinasco 2
Gunzenhausen 2
Houston 2
Jinan 2
Karaj 2
Leeuwarden 2
Milan 2
Munich 2
Ningbo 2
Nuremberg 2
Orange 2
Shoreview 2
Ardabil 1
Berlin 1
Bisceglie 1
Bishkek 1
Bloomfield 1
Borås 1
Canberra 1
Cedar Knolls 1
Clifton 1
College Station 1
Copenhagen 1
Dalmine 1
Dearborn 1
Foshan 1
Frankfurt am Main 1
Fuzhou 1
Guangzhou 1
Haikou 1
Hong Kong 1
Kajang 1
Kavir 1
Los Angeles 1
Ludwigshafen 1
Markham 1
Ottawa 1
Prineville 1
Pune 1
Santa Clara 1
Sarajevo 1
Seattle 1
Shiraz 1
Sopron 1
St Petersburg 1
Sydney 1
Tallinn 1
Walnut 1
Washington 1
Zhengzhou 1
Totale 914
Nome #
Expression and purification of the heme exporter FLVCR1a 75
Crystal structures and atomic model of NADPH oxidase 65
A closer look into NADPH oxidase inhibitors: Validation and insight into their mechanism of action 63
Selective ligands for the angiotensin ii receptors 59
Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form 57
MUTATED FORM OF NADPH OXIDASES 56
Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor 50
CRYSTAL STRUCTURES AND ATOMIC MODEL OF NADPH OXIDASE, AN INTEGRAL MEMBRANE FLAVO-ENZYME 46
Versatile medium-throughput strategies for recombinant expression screening in structural biology 46
Is neuronal nitric oxide involved in adjuvant-induced joint inflammation? 45
Electronic sculpting of ligand-GPCR subtype selectivity: The case of angiotensin II 44
Comparison of seven different heterologous protein expression systems for the production of the serotonin transporter 44
Engineering stability in NADPH oxidases: A common strategy for enzyme production 44
Recombinant human dihydroxyacetonephosphate acyl-transferase characterization as an integral monotopic membrane protein 43
The structure of monoamine oxidases: past, present, and future 43
MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM 41
Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin 39
A mutagenesis and screening strategy to generate optimally thermostabilized membrane proteins for structural studies 38
Regulation of the serotonin transporter by interacting proteins 36
SCULPTING GPCR PEPTIDE-LIGAND SUBTYPE SELECTIVITY: TACKLING CANCER VIA A NOVEL DRUG TARGET 32
On the mechanism of calcium-dependent activation of NADPH oxidase 5 (NOX5) 30
Structure of the adenosine A 2A receptor in complex with ZM241385 and the xanthines XAC and caffeine 29
Enzyme Engineering 28
Thermostabilization of the Neurotensin Receptor NTS1 26
Structure and mechanisms of ROS generation by NADPH oxidases 26
Structure of the photoreceptor synaptic assembly of the extracellular matrix protein pikachurin with the orphan receptor GPR179 24
Single Peptide Backbone Surrogate Mutations to Regulate Angiotensin GPCR Subtype Selectivity 19
EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling 18
Methods for screening for binding partners of G-protein coupled receptors 13
Mutant neurotensin receptors with improved stability 11
Mutant adenosine receptors with improved stability 10
Totale 1.200
Categoria #
all - tutte 6.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 0 0 0 0 0 0 3 1 8 13 37 1
2020/202170 4 0 0 6 6 2 15 12 9 0 1 15
2021/2022134 2 1 13 3 0 3 2 6 9 6 15 74
2022/2023386 50 23 16 15 16 30 3 16 199 3 11 4
2023/2024159 22 21 6 11 15 18 11 8 1 6 12 28
2024/2025127 18 39 6 16 29 19 0 0 0 0 0 0
Totale 1.200